Why Quality Shareback is the Missing Fuel for the Healthcare Interoperability Engine

The question is no longer whether shareback matters. It is whether the healthcare ecosystem is willing to prioritize it in practice by recognizing it in policy measurement, monitoring, and enforcement, as well as investing in the technical and governance structures needed to make shareback routine, high-quality, measurable, and reportable. The post Why Quality Shareback is…

Read More

Shifting Our Focus to Sample Sensitivity: The Metric That Deserves More Attention in Respiratory Care

The positive ripple effect of high specimen sensitivity influences the clarity of diagnoses, the timing of treatment and the efficiency of care delivery across systems, while also protecting communities from further disease spread for stronger outbreak control. The post Shifting Our Focus to Sample Sensitivity: The Metric That Deserves More Attention in Respiratory Care appeared…

Read More

Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder IPF

Boehringer Ingelheim’s Jascayd blocks a protein involved in the lung inflammation that develops from idiopathic pulmonary fibrosis, a rare and ultimately fatal disease with few available therapies. The twice-daily pill doesn’t cure IPF but clinical trial results showed it slowed disease progression. The post Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder…

Read More

Monkeypox : Symptoms, Causes, Diagnosis & Treatment

WHO has declared monkeypox or Mpox a global emergency and pandemic, given the recent outbreak in multiple countries across the world. The Mpox virus is native to Africa, but 2022-2023 has seen Mpox outbreaks in more than 110 countries. A highly infectious disease, Mpox has already infected over 1 lakh people and has already claimed…

Read More

‘We Dissent’: NIH Workers Protest Trump Policies That ‘Harm the Health of Americans’

The letter is an extraordinary rebuke of the Trump administration’s actions against the NIH, which include: terminating hundreds of grants funding scientific and biomedical research; firing more than 1,000 employees this year; and moving to end billions in funds to partner institutions overseas. The post ‘We Dissent’: NIH Workers Protest Trump Policies That ‘Harm the…

Read More